Posts Tagged ‘Funding’
CNS Therapy secures a CHF 1.1 Million investment
The Jura-based start-up, CNS Therapy, has raised a seed round funding totalling CHF 1 Million from private investors and CHF 139,200 in Jura Cantonal funding. CNS Therapy is developing a drug-free pain relief management solution that combines the use of a patented medical device with interactive therapy. While many traditional treatments for chronic…
Read MoreCHF 3 Million for Terapet and two South Korea partners
Terapet SA together with their South Korean partners Yonsei Cancer Center (Heavy Ion Therapy Center) and Oncosoft Inc. are awarded CHF 3 Million in non-dilutive funds through a bilateral innovation project funded by Innosuisse and the Korea Institute for Advancement of Technology (KIAT). Terapet SA, a Geneva-based CERN spin-off developing an innovative platform…
Read MoreHeroSupport wins a CHF 150,000 Venture Kick Grant
The HUG and UNIGE spin-off wants to improve cancer treatment universal access with tailored patient-positioning medical devices and standardized workflows. The Venture Kick Grant stage 2 will help the medtech start-up bring the product to its first customers. Breast cancer which affects 1 out of 8 women. Radiotherapy is an effective treatment, but…
Read MoreDebiopharm Innovation Fund: a new seed fund dedicated to Digital Health
Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management, announces the launch of its new seed funding initiative. It plans to deploy additional capital to support up to 15 seed-stage startups each year. Building on its strong track record of investing in 25 companies since…
Read MoreA consortium led by Addex Therapeutics secures a €4 million Eurostars grant
The Geneva-based pharmaceutical company will use the grant to support its programme for mild neurocognitive disorders (mNCD). The project, called COGNI+, aims to develop clinical candidates ready for IND enabling studies and is led by a consortium that includes Naason Science (South Korea), BioAxis Research (Netherlands), Pharmidex Pharmaceutical Services (UK), and Stichting Radboud…
Read MoreMedicxi announces a $400m fund for life sciences projects
Medicxi, a leading European life sciences investment firm, announces its $400 million Medicxi IV fund. The new fund will continue to support drug hunters with clear product visions to deliver transformative therapies for patients. Medicxi’s investments have resulted in the development of several marketed and late-stage development drugs, including Daratumumab (Genmab/Johnson & Johnson),…
Read MoreSulfiscon and biped.ai recipients of the Biopôle Start-up Fund
The fund offers up to CHF 90,000 a year, over three consecutive years, to promising life sciences ventures. Sulfiscon develops small molecule allosteric modulators that can be administered as drugs to treat pathological calcification disorders. Pathological calcification can affect different organs and is associated with ageing and diseases. At present, surgery is the…
Read MoreFONGIT Innovation Initiation Program for Life Sciences – and Deep Tech Projects
In 2016 FONGIT, in Geneva, and EPFL Innovation Park launched the Geneus program – the first innovation initiation program – transforming life sciences research into startup projects. After 7 successful years in which 150 innovators were supported, FONGIT has upgraded this program and extended the approach to all areas of deep tech, becoming the FONGIT…
Read MoreEBAMed raises EUR 14.35 Million in Series A Funding
The Swiss Health Valley start-up develops a novel image guidance system for the non-invasive treatment of Ventricular Tachycardia through Proton Therapy EBAMed SA, a Geneva-based company specializing in the development of novel image guidance systems for ventricular arrhythmias, announced today the raising of 14.35 M € in Series A Funding to accelerate the…
Read More6 life sciences startups in the Top 10 of the W. A. de Vigier Award
From a record number of over 300 submitted projects, the jury picked their Top 10. On 20 June 2023, up to five of those young leaders will receive a W. A. de Vigier Award, each endowed with CHF 100,000 biped AG from Epalinges (VD) – Independence for the Visually Impaired 270 million visually impaired…
Read More